Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
108.26
(
0.12%
)
Bitcoin
67,939.46
(
0.15%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ciotera

Send PM Follow Ignore
Followers 8
Posts 512
Boards Moderated 0
Alias Born 08/03/2005

ciotera

Re: dav1234 post# 160226

Tuesday, 04/23/2013 1:11:16 PM

Tuesday, April 23, 2013 1:11:16 PM

Post# of 257269

GILD already filed an FDA NDA for its sofosbuvir treatment.



while technically true, the all-oral sofosbuvir NDA that has been filed is for GT2/3s. As far as GT1 is concerned, the race is still on.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today